Basics Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. IPO Date: December 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $44.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.65% Avg Daily Range (30 D): $0.04 | 2.82% Avg Daily Range (90 D): $0.05 | 2.77% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 227 Avg Trade Size (Sh.) (30 D): 211 Avg Trade Size (Sh.) (90 D): 225 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 11.5K         News Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: Globe Newswire Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: N/A Jul 10, 2024 @ 12:41 PM Fortress Biotech CEO buys $36.7k in preferred stoc... Source: Investing.Com Jul 8, 2024 @ 7:10 AM Greenbrier, Fortress Biotech And 3 Stocks To Watch... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.96 $-.76 $-.73 Diluted EPS $-2.96 $-.76 $-.73 Revenue $ 62.5M $ 14.63M $ 14.9M Gross Profit $ 37.84M $ 9.34M $ 8.36M Net Income / Loss $ -123.53M $ -26.69M $ -28.82M Operating Income / Loss $ -106.06M $ -22.1M $ -27.79M Cost of Revenue $ 24.66M $ 5.29M $ 6.54M Net Cash Flow $ 8.62M $ M $ M PE Ratio     Splits Oct 10, 2023:   15:1 Dec 06, 2022:   10:1